Patrys

Patrys ROCE

The Return on Capital Employed (ROCE) of Patrys (PAB.AX) as of Nov 14, 2026 is -33.64 %. In the previous year, Return on Capital Employed (ROCE) was -369.72 % — a change of -90.90% (higher).

ROCE

-33.64 %

YoY

-90.90%

Last updated:

In 2026, Patrys's return on capital employed (ROCE) was -33.64 %, a -90.90% increase from the -369.72 % ROCE in the previous year.

The Patrys ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2019
-46.75 AUD
Jan 1, 2020
-71.62 AUD
Jan 1, 2021
-48.65 AUD
Jan 1, 2022
-84.71 AUD
Jan 1, 2023
-144.22 AUD
Jan 1, 2024
-101.99 AUD
Jan 1, 2025
-369.72 AUD
Jan 1, 2026
-33.64 AUD
The Patrys ROCE history
YEARROCEYoY
-33.64 %-90.90%
-369.72 %+262.51%
-101.99 %-29.28%
-144.22 %+70.24%
-84.71 %+74.13%
-48.65 %-32.08%
-71.62 %+53.20%
-46.75 %+36.51%
-34.25 %-61.35%
-88.62 %+87.24%
-47.33 %-46.06%
-87.74 %+49.84%
-58.56 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Patrys Stock analysis

What does Patrys do? The company Patrys Ltd is a biotechnology company based in Perth, Australia. It was founded in 2001 by a team of scientists and investors with the aim of developing and marketing targeted cancer treatments. Patrys focuses on the development of monoclonal antibodies and peptides containing therapeutic agents for cancer treatment. The main business model of Patrys is to develop and market new treatment options for cancer patients. The company utilizes the latest advancements in cancer research to develop innovative therapies tailored to the specific characteristics of each type of cancer. Patrys collaborates with leading scientists, research organizations, and pharmaceutical companies to develop a comprehensive portfolio of cancer treatments. Patrys has different business areas, all focused on the development of cancer treatments. One of these areas is the field of monoclonal antibodies, where Patrys concentrates on developing antibodies that can recognize and target specific proteins in cancer tissue. Another area focuses on the development of peptides specifically tailored to cancer cells. Patrys' products cover a variety of cancer types, including lung cancer, breast cancer, prostate cancer, colorectal cancer, and leukemia. The company's leading product is currently the antibody therapeutic PAT-LM1, used for the treatment of lung cancer. PAT-LM1 is a monoclonal antibody that targets a specific protein in the tumor, effectively combating the disease. The drug is currently in phase II clinical trials and showing promising results. Patrys is a company operating in a growing market. The global demand for cancer treatments is increasing, and Patrys has established itself as a significant player in this field. The company has gained recognition in recent years for its innovative therapy approaches and strong research and development team. Patrys aims to provide cancer patients with real hope for a cure and improve their quality of life. Overall, Patrys is a company operating in a rapidly growing market with a promising future. The company has developed a wide range of cancer treatments and works closely with leading experts and pharmaceutical companies to strengthen its position as an innovative and relevant player in cancer research. Patrys has a clear vision that it pursues, presenting an opportunity to play a significant role in the near future in a rapidly growing and highly relevant market. Patrys is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Patrys's Return on Capital Employed (ROCE)

Patrys's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Patrys's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Patrys's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Patrys’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Patrys stock

Return on Capital Employed (ROCE) of Patrys is -33.64 % in 2026.

Return on Capital Employed (ROCE) of Patrys changed from -369.72 % to -33.64 %, representing a -90.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Patrys since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Patrys with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Patrys

All Key Metrics — Patrys